Table 3.

All MHV Tools and Outcomes Model Results, 1st/99th Percentile Truncated and Normalized

Cohort	Tool of interest	Patients represented	Estimate	Confidence interval
Outcome: adherence
Refill access	Rx refill for ART	3746	0.0212*	(0.0079, 0.0345)
Refill access	Rx refill use	3746	0.0202*	(0.0055, 0.0349)
Full access	Secure messaging	4899	0.0148*	(0.0025, 0.0271)
Full access	View appointments	4899	0.0107*	(0.0020, 0.0194)
Full access	View labs	4899	0.0045	(−0.0055, 0.0145)
Outcome: viral load suppression
Refill access	Rx refill for ART	3560	1.2202	(0.9402, 1.5836)
Refill access	Rx refill use	3560	1.2573	(0.9764, 1.6190)
Full access	Secure messaging	4651	0.8896	(0.7157, 1.1058)
Full access	View appointments	4651	0.9402	(0.7733, 1.1431)
Full access	View labs	4651	1.2943*	(1.0032, 1.6700)
Outcome: viral load test receipt
Refill access	Rx refill for ART	3560	1.1027	(0.9282, 1.3101)
Refill access	Rx refill use	3560	1.0633	(0.8839, 1.2792)
Full access	Secure messaging	4651	1.1252	(0.9531, 1.3284)
Full access	View appointments	4651	1.1877*	(1.0545, 1.3377)
Full access	View labs	4651	0.8772	(0.7572, 1.0163)

Refill access = PLWH who at least have access to the access Rx refill tool; full access = PLWH who have access to all tools. *Finding is significant at the α = 0.05 level